SUMO2 glycosylation and GLUT1 ubiquitination promoted GLUT1 degradation and activated the AMPK–mTOR pathway through glycolytic inhibition, leading to nasopharyngeal carcinoma cell proliferation and metastasis136. This evidence concerns the gene SLC2A1 and nasopharyngeal carcinoma.